Friday, January 4, 2013

Durham-tested Drug Approved by FDA



Apixaban, a drug aimed at preventing strokes, has been approved by the U.S. Food and Drug Administration. New York-based Bristol-Myers Squibb and New York-based Pfizer Inc. partnered to develop the drug, and tested it at Duke University in Durham.


No comments:

Post a Comment